Oncopeptides wins SwedenBIO Award 2017

We are happy and proud to congratulate our client Oncopeptides for winning the prestigious SwedenBIO Award 2017. Oncopeptides has developed Ygalo, a drug for treating hematologic cancer.

The SwedenBIO Award is awarded to companies in Life Science for their outstanding achievement.

Awapatent IP team, headed by Tomas Lundquist, works in close collaboration with Oncopeptides, in order to protect their assets, through patents and trademarks.